AI-generated summary
The authors studied 60 participants with recent, old, or acne scars who received red 660 nm laser photobiomodulation sessions. They report statistically significant improvements in scar color, size, and patient satisfaction across groups, with no adverse effects noted. The abstract does not describe a control group, so the findings are reported as observed outcomes.
- Participants
- 60
- Who or what was studied
- 60 participants with recent scars (under 6 months), old scars (over 1 year), or acne scars
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not describe a control group or the size of the reported improvements, so the strength of the evidence is unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Low-level laser therapy, Fluence, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.